The Global Albumin Market is expected to grow at a rate of 6% by 2026. The development of albumin-based nanoparticles for drug delivery, high demand for albumin in R&D activities & clinical trials, ...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted UK pharma major GSK’s regulatory application to expand the ...

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...

The new COVID-19 variant NB.1.8.1, known as Nimbus, is causing concern due to its subtle symptoms and high transmission rate.

Martin Vollmer, biopharma program manager at Agilent Technologies, spoke to LCGC International about the evolving importance of glucagon-like peptide-1 (GLP-1) therapeutics and the challenges they ...

Figure 1: Immunization with recombinant yeast elicits antigen-specific, T-cell protective, cytotoxic and proliferative responses. Figure 2: DCs internalize yeast and efficiently prime MHC class I ...

GSK plc has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted the company's regulatory ...

HTAC Thermal Decomposition Water Dynamics WNP's toner features Italian patented HTAC technology, which protects red algae and ...

Non-Oncology Biopharmaceuticals Market to hit US$ 313.70B by 2033, driven by rising demand for biologics, biosimilars & gene therapies for rare diseases.

Updated: June 20, 2025 - Upcoming non-Equity auditions including regional theater auditions, community theatre and national tour casting calls. Date Added Audition Date ...

前言2025年7月12日至15日，第107 届美国内分泌协会年会（ENDO ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.